378 related articles for article (PubMed ID: 25605020)
1. Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression.
Yu S; Cai X; Wu C; Wu L; Wang Y; Liu Y; Yu Z; Qin S; Ma F; Thiery JP; Chen L
Oncotarget; 2015 Feb; 6(5):2951-65. PubMed ID: 25605020
[TBL] [Abstract][Full Text] [Related]
2. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
3. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099
[TBL] [Abstract][Full Text] [Related]
4. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling.
Lai CJ; Lin CY; Liao WY; Hour TC; Wang HD; Chuu CP
Cells; 2019 Mar; 8(4):. PubMed ID: 30935014
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
[TBL] [Abstract][Full Text] [Related]
6. Low shear stress induces ERK nuclear localization and YAP activation to control the proliferation of breast cancer cells.
Qin X; Li J; Sun J; Liu L; Chen D; Liu Y
Biochem Biophys Res Commun; 2019 Mar; 510(2):219-223. PubMed ID: 30685085
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
8. The Emerging Role of the Hippo Pathway in Lung Cancers: Clinical Implications.
Teoh SL; Das S
Curr Drug Targets; 2017 Nov; 18(16):1880-1892. PubMed ID: 27628948
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
Bourguignon LY; Singleton PA; Zhu H; Diedrich F
J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
[TBL] [Abstract][Full Text] [Related]
10. Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.
Zhang S; Chen Q; Liu Q; Li Y; Sun X; Hong L; Ji S; Liu C; Geng J; Zhang W; Lu Z; Yin ZY; Zeng Y; Lin KH; Wu Q; Li Q; Nakayama K; Nakayama KI; Deng X; Johnson RL; Zhu L; Gao D; Chen L; Zhou D
Cancer Cell; 2017 May; 31(5):669-684.e7. PubMed ID: 28486106
[TBL] [Abstract][Full Text] [Related]
11. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
12. Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma.
Fan Z; Xia H; Xu H; Ma J; Zhou S; Hou W; Tang Q; Gong Q; Nie Y; Bi F
Biomed Pharmacother; 2018 Jul; 103():147-156. PubMed ID: 29649630
[TBL] [Abstract][Full Text] [Related]
13. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
14. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.
Zhao X; Wang X; Fang L; Lan C; Zheng X; Wang Y; Zhang Y; Han X; Liu S; Cheng K; Zhao Y; Shi J; Guo J; Hao J; Ren H; Nie G
Cancer Lett; 2017 Aug; 402():61-70. PubMed ID: 28576749
[TBL] [Abstract][Full Text] [Related]
15. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
16. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Bourguignon LY; Gilad E; Peyrollier K
J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
18. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of Yes-Associated Protein Induces the Apoptosis While Inhibits the Proliferation of Human Periodontal Ligament Stem Cells through Crosstalk between Erk and Bcl-2 Signaling Pathways.
Wen Y; Ji Y; Zhang Y; Jiang B; Tang C; Wang Q; Chen X; Jia L; Gu W; Xu X
Int J Med Sci; 2017; 14(12):1231-1240. PubMed ID: 29104479
[No Abstract] [Full Text] [Related]
20. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
Shen J; Cao B; Wang Y; Ma C; Zeng Z; Liu L; Li X; Tao D; Gong J; Xie D
J Exp Clin Cancer Res; 2018 Jul; 37(1):175. PubMed ID: 30055645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]